Hematology in transition: Diagnostic depth, therapeutic breadth, and clinical curiosity

Each issue of the Journal of Hematology and Allied Sciences offers exciting variety of contemporary hematology research. The current issue weaves together laboratory innovation, and exciting clinical insights through case series and reports. At the heart of this edition is an article meticulously comparing singleplatform and doubleplatform methods for cluster of differentiation 34⁺ (CD34) hematopoietic stem cell enumeration. This is pertinent to the Indian setting as it brings in the vital cost issue that applies to many of the centers performing transplant. The standard International Society of Hematotherapy and Graft Engineering recommended methods were compared to show concordance with a clear cost advantage of one over the other which is crucial to centers performing cutting edge transplant work with limited resources.

The utility of modern hematology analyzers extends far beyond simple enumeration of blood counts and indices. Hematopathologists worldwide continue to demonstrate the diagnostic and prognostic potential of these tools, extracting clinically meaningful insights that aid in disease prediction and risk stratification. From cardiovascular medicine to critical care and beyond, hematologic parameters are increasingly being recognized as valuable biomarkers, reinforcing the analyzer’s role as a cornerstone of modern diagnostic medicine. A critical review “Beyond anemia: Red cell distribution width as a universal biomarker” highlights the transformative potential of RDW as a costeffective, widely accessible biomarker in various specialties of medicine. Another review explores the role of pregnancy specific biologics in managing chronic non-healing ulcers, a difficult to manage clinical condition.

Lymphoma remains a diagnostically intriguing disease, made all the more compelling by the rapid evolution of immunohistochemistry panels and the integration of molecular diagnostics that now allow for precise subtyping and risk stratification. Yet, one of the persistent challenges lies in the anatomical site of involvement. Accurate diagnosis hinges on obtaining an adequate biopsy from the most informative site – an endeavor that is often easier said than done. The case series titled “Unusual Lymphomas: Unusual Sites” compellingly disrupts conventional expectations about lymphomatous localization, urging clinicians and pathologists alike to broaden their diagnostic lens. It reinforces a key lesson in hematopathology: Lymphoma can, and often does present in unexpected places, defying standard anatomical assumptions and demanding a high index of suspicion.

The collection of case reports in this issue offers valuable insights relevant to everyday hematology practice. One highlights how exogenous substances can interfere with diagnostic assays such as serum protein electrophoresis, leading to aberrant bands that may mimic paraproteinemia underscoring the critical importance of clinical correlation in avoiding misdiagnosis. Another report details an opportunistic fungal infection complicating the management of non-Hodgkin lymphoma, reminding clinicians of the infectious vulnerabilities that can accompany hematologic malignancies and their treatment. Of particular interest is the evolving role of Venetoclax, a BCL-2 inhibitor originally approved for lymphoid malignancies and acute myeloid leukemia which is now finding expanded utility in refractory hematologic diseases. A notable case in this issue describes a patient with refractory acute promyelocytic leukemia and central nervous system relapse who achieved durable remission with venetoclax maintenance. This case not only demonstrates the therapeutic promise of venetoclax beyond its conventional indications but also offers hope in scenarios where standard treatment options have been exhausted.

As we reflect on these contributions, two overarching themes emerge: The integration of precision diagnostics, and the exploration of rare yet instructive clinical scenarios that deepen our understanding of hematologic processes. Together, they enrich the corpus of hematology, guiding future investigative directions and reinforcing the journal’s role as both a scholarly forum and a clinical resource.